Go Back
0:17:14
0:07:43
0:15:00
0:14:56
0:14:20
0:03:29
0:14:36
0:05:27
0:08:44
0:19:57
0:04:38
0:07:23
0:15:16
0:11:46
0:13:49
0:15:40
0:04:11
0:08:54
0:09:29
0:07:00
0:15:19
0:08:02
0:17:37
0:11:28
Latest Videos
Alexander Eggermont, MD @GustaveRoussy #ESMO20 #melanoma Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Final results
Zarnie Lwin, MD @zarnielwin @RBWHFoundation LBA41 - LEAP-005: Phase II study of len plus pembro in pts with previously treated AST
John Bridgewater, MD, Ph.D. @uclcancer #livercancer Phase 2 Study FOENIX-CCA2 and Efficacy and Safety of Futibatinib
Dr. Neal Shore MD, FACS @AtlanticUrology #ESMO20 #prostatecancer Tolerability and treatment response in the phase 3 ARAMIS trial - Nonmetastatic, Castration-Resistant Prostate Cancer and ...
Susanna Curtis, MD @YaleCancer @YaleMed Medical Marijuana Associated with Fewer Hospitalizations for Individuals Living with SCD
Erika P. Hamilton, MD @ErikaHamilton9 @SarahCannonDocs #ESMO20 #breastcancer LIO-1: A Phase 2 study of lucitanib + nivolumab and Initial clinical experience of lucitanib + nivolumab
Neal Shore, MD @AtlanticUrology @Myovant #prostatecancer ESCALATE Trial Potential Enhancement of Prostate Cancer Treatment Options: First Patient Randomized in Phase III Trial
Lillian Siu, MD @pmcancercentre @lillian_siu #ESMO20 #advancedsolidtumors Initial Results of a Phase 1 Study of MK-4830, a First-in-Class Anti-Immunoglobulin-Like Transcript 4
Eric Jonasch, MD @MDANdersonNews #ASCO20 #renalcellcarcinoma #vonhippellindau #VHL Phase II study of the oral HIF-2α inhibitor MK-6482
Robert Coleman, MD, FACOG, FACS @USOResearch #ASCO20 #SSC #PBC #ovariancancer A phase III randomized controlled trial of secondary surgical cytoreduction
Erik A. Williams, MD @FoundationATCG #softtissuesarcoma CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1
Paolo Ghia, MD, Ph.D. @MyUniSR #RRCLL #CLL ASCEND: Phase III, Randomized Trial of Acalabrutinib
Xiang Cheng Ph.D. and Feng Geng Ph.D. @OSUCCC_James #braincancer Blocking Fat Storage Might Offer New Way to Treat Most Lethal Form of Brain Cancer
S. Michelle Shiller, DO, AP/CP, MGP @PathGroupLabs @LUNGevity Pan-Cancer Consortium Moves to Clarify and Promote Consistent Use of Common Terms for Biomarker and Germline Genetic Testing
Ari Melnick, MD @LabMelnick @WeillCornell @ASH_hematology American Society of Hematology Ernest Beutler Lecture and Prize
Edward J. Benz, Jr., MD @DanaFarber @DanaFarberNews @ASH_hematology @DanaFarberNews American Society of Hematology Leadership in Promoting Diversity and the road ahead
Ammar Chaudhry, MD @cityofhope @AACR #AACR20 #glioblastoma Randiomic prediction of survival in recurrent high-grade glioma patients
Shailja Shah, MD, Ph.D. @VUMC_Cancer Study gauges specific site gastric cancer risks among ethnic groups
Nick Smith-Stanley, MBA @livestrong @DellMedSchool #women #oncology Addressing the Disparity of Women in Oncology and Live
Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
Greg Hiebert Leadership Forward @GregHiebert #leadership Leadership Resilience and Post Traumatic Growth and Live
David R. Gandara, MD @MDAndersonNews @GuardantHealth Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood draw
Minesh P Mehta MD, FASTRO @BaptistHealthSF High- vs Low-Dose Radiation for Adult Low-Grade Glioma
